C. Pivot

发表

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients

X. Thomas, F. Barraco, F. Nicolini, 2013, Cancer.

A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared–ultraviolet spectrophotometry

F. Pirot, C. Pivot, F. Dziopa, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.

P. Cony-Makhoul, S. Hayette, V. Maguer-Satta, 2015, The Lancet. Haematology.

Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone.

J. Magaud, M. Tulliez, S. Hayette, 2011, Leukemia research.

Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks.

C. Mouchoux, A. Janoly-Dumenil, F. Ranchon, 2021, Research in social & administrative pharmacy : RSAP.

Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial

L. Mazzola, P. Convers, S. Rheims, 2022, The Lancet Neurology.

New easy handling and sampling device for bioavailability screening of topical formulations

B. Verrier, F. Pirot, M. Haftek, 2015, European Journal of Dermatology.

How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)?

C. Rioufol, S. Goutelle, L. Bourguignon, 2021, Clinical interventions in aging.

Evaluation of Safe Infusion Devices for Antineoplastic Administration

C. Pivot, G. Galy, L. Lalande, 2012, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Impact of a paediatric-adult care transition programme on the health status of patients with sickle cell disease: study protocol for a randomised controlled trial (the DREPADO trial)

Y. Bertrand, F. Galactéros, A. Hot, 2019, Trials.

Surface and human contamination with 5-fluorouracil in six hospital pharmacies

F. Rull, C. Ardiet, V. Dubois, 2001 .

Long-term stability of gentamicin sulfate-ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) solution for catheter locks

D. Lebeaux, J. Ghigo, F. Pirot, 2017, Journal of pharmaceutical analysis.

Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial

B. Gilbert-Dussardier, F. Gueyffier, G. Grenet, 2019, BMC Pediatrics.

Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation

B. Souweine, S. Jaber, J. Timsit, 2017, The Journal of antimicrobial chemotherapy.

Dual 0.02% chlorhexidine digluconate - 0.1% disodium EDTA loaded thermosensitive ocular gel for Acanthamoeba keratitis treatment.

M. Pélandakis, F. Pirot, A. Risler, 2019, International journal of pharmaceutics.

Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis.

F. Pirot, F. Falson, C. Burillon, 2010, International journal of pharmaceutics.

Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation.

F. Pirot, D. Salmon, C. Pivot, 2013, International journal of pharmaceutics.

Implementation and effectiveness of pharmacist-led interviews at patient hospital admission in a rheumatology department

R. Chapurlat, C. Confavreux, A. Janoly-Dumenil, 2021, European journal of hospital pharmacy : science and practice.

[Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract].

T. Ponchon, J. Drai, F. Pirot, 2015, Annales pharmaceutiques francaises.

Infraorbital and infratrochlear nerve blocks combined with general anaesthesia for outpatient rhinoseptoplasty: A prospective randomised, double-blind, placebo-controlled study.

B. Allaouchiche, L. Bouvet, F. Disant, 2016, Anaesthesia, critical care & pain medicine.

Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial

F. Pirot, S. Filali, D. Salmon, 2017, Journal of pharmaceutical analysis.

[Innovative therapeutic strategies for intravesical drug administration].

M. Colombel, F. Pirot, R. Mărginean, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Ex vivo study of bevacizumab transport through porcine nasal mucosa.

E. Decullier, J. Scoazec, G. Paintaud, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[Pharmaceutical involvement in academic clinical trials: Quality assessment of pharmaceutical manufacturing operations].

F. Pirot, C. Pivot, M. Tall, 2015, Annales Pharmaceutiques Françaises.

Bladder tissue permeability and transport modelling of intravesical alum, lidocaine hydrochloride, methylprednisolone hemisuccinate and mitomycin C.

M. Colombel, F. Pirot, D. Salmon, 2014, International journal of pharmaceutics.

[Validation of pharmaceutical quality of a [6,6-(2)H(2)]-glucose parenteral solution used for insulin-resistance measurement during human clinical trials].

M. Laville, E. Blond, M. Désage, 2011, Annales pharmaceutiques francaises.

Assessment of the clinical relevance of pharmacists' interventions performed during medication review in a rheumatology ward.

E. Decullier, R. Chapurlat, A. Janoly-Dumenil, 2019, European journal of internal medicine.

[Hospital pharmacist has a rule for best practice use and French hospital activity tariffs. Example of a pharmaceutical quality control for drugs reimbursed in addition of DRGs].

G. Aulagner, S. Couray-Targe, X. Dode, 2012, Annales Pharmaceutiques Françaises.

Pegylated Interferon-α 2a in Combination to Nilotinib As First Line Therapy in Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Provides High Rates of MR4.5. Preliminary Results of a Phase II Study.

P. Cony-Makhoul, P. Rousselot, F. Mahon, 2012 .

[Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].

X. Thomas, A. Thiébaut, E. Archimbaud, 2000, Presse medicale.

Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy.

X. Barbaut, P. Maire, J. Vergnaud, 1994, International journal of bio-medical computing.

Production and stability study of a hospital parenteral nutrition solution for neonates

F. Pirot, P. Thomaré, S. Filali, 2018, Journal of pharmaceutical analysis.

Evaluation of Safe Infusion Devices for Antineoplastic Administration.

C. Pivot, G. Galy, L. Lalande, 2015, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Measurement, analysis and prediction of amoxicillin oral dose stability from integrated molecular description approach and accelerated predictive stability (APS)

F. Pirot, S. Filali, D. Salmon, 2020 .

Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.

P. Cony-Makhoul, S. Hayette, V. Maguer-Satta, 2015, The Lancet. Haematology.